Suppr超能文献

髓系来源的抑制细胞在流感病毒诱导的哮喘加重中的作用。

Myeloid-derived suppressor cells in influenza virus-induced asthma exacerbation.

机构信息

Institute of Laboratory Medicine, member of the German Center for Lung Research (DZL), The Universities of Giessen and Marburg Lung Center (UGMLC), Philipps University Marburg, Marburg, Germany.

Department of Experimental and Clinical Pharmacology and Pharmacogenomics, University of Tübingen, Tübingen, Germany.

出版信息

Front Immunol. 2024 Apr 17;15:1342497. doi: 10.3389/fimmu.2024.1342497. eCollection 2024.

Abstract

Myeloid-derived suppressor cells (MDSCs) are a phenotypically heterogenous group of cells that potently suppress the immune response. A growing body of evidence supports the important role of MDSCs in a variety of lung diseases, such as asthma. However, the role of MDSCs in asthma exacerbation has so far not been investigated. Here, we studied the role of MDSCs in a murine model of influenza virus-induced asthma exacerbation. BALB/c mice were exposed to house dust mite (HDM) three times a week for a total of five weeks to induce a chronic asthmatic phenotype, which was exacerbated by additional exposure to the A/Hamburg/5/2009 hemagglutinin 1 neuraminidase 1 (H1N1) influenza virus. Induction of lung inflammatory features, production of T helper (Th) 1- and Th2- associated inflammatory cytokines in the lavage fluid and an increased airway hyper-responsiveness were observed, establishing the asthma exacerbation model. The number and activity of pulmonary M-MDSCs increased in exacerbated asthmatic mice compared to non-exacerbated asthmatic mice. Furthermore, depletion of MDSCs aggravated airway hyper-responsiveness in exacerbated asthmatic mice. These findings further denote the role of MDSCs in asthma and provide some of the first evidence supporting a potential important role of MDSCs in asthma exacerbation.

摘要

髓系来源的抑制细胞(MDSCs)是一群表型异质性的细胞,能够强烈抑制免疫反应。越来越多的证据支持 MDSCs 在各种肺部疾病(如哮喘)中的重要作用。然而,MDSCs 在哮喘恶化中的作用迄今为止尚未得到研究。在这里,我们研究了 MDSCs 在流感病毒诱导的哮喘恶化的小鼠模型中的作用。BALB/c 小鼠每周接受三次屋尘螨(HDM)暴露,总共五周,以诱导慢性哮喘表型,随后再暴露于 A/Hamburg/5/2009 血凝素 1 神经氨酸酶 1(H1N1)流感病毒,从而导致哮喘恶化。观察到肺部炎症特征的诱导、灌洗液中 T 辅助(Th)1 和 Th2 相关炎症细胞因子的产生以及气道高反应性的增加,从而建立了哮喘恶化模型。与非恶化哮喘小鼠相比,在恶化哮喘小鼠中,肺部 M-MDSCs 的数量和活性增加。此外,MDSC 的耗竭加重了恶化哮喘小鼠的气道高反应性。这些发现进一步说明了 MDSCs 在哮喘中的作用,并提供了一些支持 MDSCs 在哮喘恶化中具有潜在重要作用的首批证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44c6/11061804/3d5932994bf2/fimmu-15-1342497-g001.jpg

相似文献

1
Myeloid-derived suppressor cells in influenza virus-induced asthma exacerbation.
Front Immunol. 2024 Apr 17;15:1342497. doi: 10.3389/fimmu.2024.1342497. eCollection 2024.
2
Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4.
Front Immunol. 2021 Jul 12;12:695933. doi: 10.3389/fimmu.2021.695933. eCollection 2021.
3
The impact of IL-10 and IL-17 on myeloid-derived suppressor cells in vitro and in vivo in a murine model of asthma.
Eur J Immunol. 2024 Jul;54(7):e2350785. doi: 10.1002/eji.202350785. Epub 2024 Apr 23.
5
T cells and ILC2s are major effector cells in influenza-induced exacerbation of allergic airway inflammation in mice.
Eur J Immunol. 2019 Jan;49(1):144-156. doi: 10.1002/eji.201747421. Epub 2018 Jun 11.
7
Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma model.
Am J Physiol Lung Cell Mol Physiol. 2019 Jan 1;316(1):L187-L196. doi: 10.1152/ajplung.00162.2018. Epub 2018 Oct 25.

引用本文的文献

1
The role of innate immune system in respiratory viral infection related asthma.
Front Cell Infect Microbiol. 2025 Jun 25;15:1604831. doi: 10.3389/fcimb.2025.1604831. eCollection 2025.

本文引用的文献

1
A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs.
Antioxidants (Basel). 2023 Apr 26;12(5):1005. doi: 10.3390/antiox12051005.
2
Advances in the study of myeloid-derived suppressor cells in infectious lung diseases.
Front Immunol. 2023 Mar 29;14:1125737. doi: 10.3389/fimmu.2023.1125737. eCollection 2023.
3
Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation.
Front Immunol. 2022 Aug 30;13:933847. doi: 10.3389/fimmu.2022.933847. eCollection 2022.
4
The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.
Front Immunol. 2022 Jul 13;13:930862. doi: 10.3389/fimmu.2022.930862. eCollection 2022.
5
Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management.
J Allergy Clin Immunol. 2021 Dec;148(6):1430-1441. doi: 10.1016/j.jaci.2021.10.001. Epub 2021 Oct 14.
6
Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4.
Front Immunol. 2021 Jul 12;12:695933. doi: 10.3389/fimmu.2021.695933. eCollection 2021.
8
Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases.
Cell Immunol. 2021 Apr;362:104300. doi: 10.1016/j.cellimm.2021.104300. Epub 2021 Feb 4.
9
Single-cell transcriptomic analysis reveals key immune cell phenotypes in the lungs of patients with asthma exacerbation.
J Allergy Clin Immunol. 2021 Mar;147(3):941-954. doi: 10.1016/j.jaci.2020.09.032. Epub 2020 Oct 8.
10
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
Front Immunol. 2020 Jul 30;11:1680. doi: 10.3389/fimmu.2020.01680. eCollection 2020.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验